Sign inGet started

Griffith Donald J.

Insider CIK 1663251 · SONN Chief Financial Officer, Director · ONS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SONN Sonnet BioTherapeutics Hol D To issuer2025-12-022025-12-0310,375— $00SEC↗
SONN Sonnet BioTherapeutics Hol A Award2025-07-112025-07-1510,000— $010,375SEC↗
SONN Sonnet BioTherapeutics Hol A Award2023-12-112024-12-05317— $0375SEC↗
SONN Sonnet BioTherapeutics Hol F Tax w/h2023-02-062023-02-17497$1.04 $51710,301SEC↗
SONN Sonnet BioTherapeutics Hol A Award2022-12-092023-02-173,214— $010,798SEC↗
SONN Sonnet BioTherapeutics Hol F Tax w/h2022-04-082022-04-084,507$0.37 $1.7K106,186SEC↗
SONN Sonnet BioTherapeutics Hol A Award2021-12-152022-04-0815,000— $0110,693SEC↗
SONN Sonnet BioTherapeutics Hol F Tax w/h2021-05-252021-05-284,235$1.51 $6.4K95,693SEC↗
SONN Sonnet BioTherapeutics Hol A Award2020-07-022020-07-0220,000— $099,928SEC↗
SONN Sonnet BioTherapeutics Hol A Award2020-04-012020-04-0379,928— $079,928SEC↗
ONS Oncobiologics, Inc. S Sale2016-11-232016-11-281$3.75 $4144,926SEC↗
ONS Oncobiologics, Inc. M Exercise2016-11-092016-11-14144,927— $0144,927SEC↗
ONS Oncobiologics, Inc. C Conversion2016-11-092016-11-14144,927— $00SEC↗